Comparison
20q11 2 Microdeletion Syndrome C5680063 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 20q11 2 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
20q11 2 Microdeletion Syndrome C5680063
A genetic disorder where a portion of chromosome 20 is deleted. Individuals may experience developmental delays, learning challenges, and behavioral concerns. Management includes educational support and medical care.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
20q11 2 Microdeletion Syndrome C5680063
0-null
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
20q11 2 Microdeletion Syndrome C5680063
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
20q11 2 Microdeletion Syndrome C5680063
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
20q11 2 Microdeletion Syndrome C5680063
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
20q11 2 Microdeletion Syndrome C5680063
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
20q11 2 Microdeletion Syndrome C5680063
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
20q11-2-microdeletion-syndrome-C5680063 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20q11 2 Microdeletion Syndrome C5680063 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Developmental delay | May include developmental delay; extent is not quantified here. | Varied developmental features are described, without a fixed pattern. | Low |
| Learning and behavior | Learning challenges and behavioral concerns may occur. | Specific learning or behavioral findings are not established in the source. | Moderate |
| Overall clinical severity | Labeled severe, but individual course needs clinician review. | Labeled moderate, with substantial individual variation. | Moderate |
When to favor each condition
Choose 20q11 2 Microdeletion Syndrome C5680063 when
A confirmed deletion involving 20q11.2
The genomic change matches the left condition rather than an 11p duplication.
High
Prominent learning or behavioral concerns with this deletion
These concerns are specifically mentioned for the left condition.
Moderate
Need for educational and medical support planning
Source management emphasizes educational support and medical care.
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
A confirmed duplication involving 11p15.4
The locus and duplication type distinguish it from a 20q deletion.
High
Developmental features vary and no syndrome-specific pattern is clear
The source stresses varied features and individualized assessment.
Moderate
Severity appears less marked than the severe label
The supplied severity label is moderate, but this is not a diagnosis by itself.
Low
How key tests differ
| Test | 20q11 2 Microdeletion Syndrome C5680063 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a copy-number loss at 20q11.2. | May show a copy-number gain at 11p15.4. | Locus and loss versus gain are the key distinction; report review is required. |
| Karyotype | May be normal if the deletion is below microscopic resolution. | May be normal if the duplication is small. | A normal karyotype does not exclude either condition. |
| Targeted confirmation | Orthogonal testing can confirm the reported deletion. | Orthogonal testing can confirm the reported duplication. | Confirmation and parental studies help interpretation but do not define prognosis. |
Prognosis comparison
20q11 2 Microdeletion Syndrome C5680063
- Outcome
- Long-term outcome is not established; the supplied label is severe and the course is chronic.
- Factors
- Deletion details, developmental profile, medical complications, and support access may matter.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Outcome is not established; the supplied label is moderate with varied features and a chronic course.
- Factors
- Duplication details, individual findings, and tailored care may influence needs.
Time frame: From early life onward, although exact onset is not supplied.
Genomic report, clinical assessment, family studies, and available supports; no mortality estimate is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Delays, learning difficulty, or behavioral concerns may occur. Developmental features may vary; specific complications are not established. Neither list should be treated as complete or inevitable. |
| Medical comorbidity | Associated medical needs are possible but unspecified here. Associated medical needs require individualized assessment. No exact complication rates are supplied. |
| Support needs | Educational and ongoing medical support may be needed. Support should be tailored because features vary. Needs can change over time and are not fixed by the label. |
Patient education highlights
- HighGenetic result meaning
A microarray finding is not automatically a complete diagnosis; a genetics clinician should interpret size, genes, and family studies.
- HighIndividual variation
People with the same labeled syndrome can differ. Avoid predictions based only on severity labels.
- MediumCare planning
Ask about developmental surveillance, learning support, and coordinated medical follow-up. Neither condition is communicable.